|
Arias, Albert J; Armeli, Stephen; Gelernter, Joel et al. (2008) Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. Alcohol Clin Exp Res 32:1159-66
|
|
Armeli, Stephen; Feinn, Richard; Tennen, Howard et al. (2006) The effects of naltrexone on alcohol consumption and affect reactivity to daily interpersonal events among heavy drinkers. Exp Clin Psychopharmacol 14:199-208
|
|
Hernandez-Avila, Carlos A; Song, Changhong; Kuo, Lynn et al. (2006) Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking. Alcohol Clin Exp Res 30:860-5
|
|
Kranzler, Henry R; Armeli, Stephen; Feinn, Richard et al. (2004) Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers. J Consult Clin Psychol 72:317-27
|
|
Kranzler, Henry R; Armeli, Stephen; Tennen, Howard et al. (2003) Targeted naltrexone for early problem drinkers. J Clin Psychopharmacol 23:294-304
|
|
Oslin, David W; Berrettini, Wade; Kranzler, Henry R et al. (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546-52
|
|
Feinn, Richard; Tennen, Howard; Kranzler, Henry R (2003) Psychometric properties of the short index of problems as a measure of recent alcohol-related problems. Alcohol Clin Exp Res 27:1436-41
|
|
Feinn, Richard; Tennen, Howard; Cramer, Joyce et al. (2003) Measurement and prediction of medication compliance in problem drinkers. Alcohol Clin Exp Res 27:1286-92
|
|
Kranzler, Henry R; Amin, Hetal; Cooney, Ned L et al. (2002) Screening for health behaviors in ambulatory clinical settings: does smoking status predict hazardous drinking? Addict Behav 27:737-49
|
|
Kranzler, H R; Van Kirk, J (2001) Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res 25:1335-41
|
Showing the most recent 10 out of 13 publications
